CKD-495 75mg

DRUG2 trials

Sponsors

Chong Kun Dang Pharmaceutical

Conditions

Gastritis

Phase 2

Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 Tablet

CompletedNCT03437785

Chong Kun Dang PharmaceuticalGastritis

Start: 2018-01-16End: 2018-10-12Updated: 2018-10-31

Phase 3

A Clinical Trial to Evaluate the Efficacy and Safety of CKD-495

CompletedNCT04255589

Chong Kun Dang PharmaceuticalGastritis

Start: 2020-01-06End: 2021-05-20Updated: 2021-07-02

Related Papers

A Phase 2, Multi‐Center, Randomized, Double‐Blind, Parallel‐Group Trial to Evaluate the Efficacy and Safety of CKD‐495 in Patients With Acute and Chronic Gastritis

Canadian Journal of Gastroenterology and Hepatology2025-01-012 citations

Efficacy and safety of CKD-495 in acute and chronic gastritis: A Phase III superiority clinical trial

Medicine2023-12-085 citations